By Clarivate Analytics – Formerly the IP&Science business of Thomson Reuters
To listen to an audio podcast, mouse over the title and click Play. Open iTunes to download and subscribe to podcasts.
Cancer immunotherapy represents a growing research field and is emerging as a powerful weapon for cancer treatment, although it is not yet as widely used as surgery, chemotherapy, and radiation therapy. This series of podcasts aims to disseminate the scientific landscape in immuno-oncology to professionals in the field, with comprehensive insights from industry experts, presented in concise and digestible episodes.
||CleanRevolutionizing the IO Market Through R&D Funding and Partnerships||Immuno-oncology therapies have opened up the most promising frontiers in cancer treatment today. But, with drug development costs increasing, how is it possible to maintain commercial viability? - Peter Winter, Editor at BioWorld,||7 3 2017||Free||View in iTunes|
||CleanExploring the Transformative Potential of Checkpoint Inhibitors and CAR T-Cells||Cancer immunotherapy research continues to evolve and offers patients a transformative alternative to traditional therapies. Anette Briendl, Senior Science Editor at BioWorld, talks about the current research landscape for immunotherapies.||12 2 2017||Free||View in iTunes|
||CleanHow CRISPR is Revolutionizing the Treatment of Genetic Diseases||The recent buzz around CRISPR-Cas9, a genome editing tool, has revolved around its potential for treating various genetic diseases, including cancer. Jack Hopwood, Intellectual Property Consultant and Bertrand Sautier,||23 1 2017||Free||View in iTunes|
||CleanAccelerating the Development of Cancer Treatment with Data Visualization||Recently, the U.S. Patent and Trademark Office's released a dataset that contained over 250,000 records, included patent applications and granted patents; the USPTO was interested in the insights this data could reveal to guide cancer research. Di Cross||30 12 2016||Free||View in iTunes|
||CleanImproving Patient Outcomes with New Approved Drugs||Join Chris Willis, Manager of Discovery and Translational Sciences at Clarivate Analytics, as he talks about immuno-oncology, why it is promising for cancer patients and how it continues to evolve. Learn more about the new approved drugs on the market .||12 12 2016||Free||View in iTunes|
||CleanUnderstanding the Cancer Research Landscape||The Cancer Moonshot Initiative is intended to accelerate the pace of cancer research. The field of cancer immunotherapy presents real promise for cancer patients – offering a less toxic treatment protocol that reduces their suffering. Amy Braden,||28 11 2016||Free||View in iTunes|
||CleanHow Science is Harnessing Immuno-Oncology||Historically, clinicians have fought cancer with tools such as radiation, surgery and chemotherapy, which kill cancerous cells, but also damage healthy cells or nearby tissues. Immuno-oncology presents a whole new treatment paradigm; it tunes the immun.||18 11 2016||Free||View in iTunes|
||CleanOncology Talks – Coming Soon||Clarivate Analytics Oncology Talks provides expert insights on key issues and trends in the areas of oncology research.||3 11 2016||Free||View in iTunes|
Listeners also subscribed to
- FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)
- U.S. Food and Drug Administration, Center for Drug Evaluation and Research
- View in iTunes